首页 | 本学科首页   官方微博 | 高级检索  
     

耐顺铂人肺腺癌细胞系A549^DDP耐药机理进一步探讨
引用本文:詹茂程 刘叙仪. 耐顺铂人肺腺癌细胞系A549^DDP耐药机理进一步探讨[J]. 中国肿瘤临床, 1998, 25(10): 726-728
作者姓名:詹茂程 刘叙仪
作者单位:北京医科大学临床肿瘤学院内二科
基金项目:国家“九五”攻关项目基金
摘    要:应用递增浓度的方法建立了一株顺铂(CDDP)耐药细胞系A549DDP。用溴化乙啶荧光分光光度法测定细胞内Pt-DNA链间交联物(ICL);用无焰原子吸收光谱法测定细胞浆内及细胞核内铂含量;用流式细胞法及荧光显微镜测定铂的外排速度。结果显示:耐药细胞A549DDP较亲代敏感细胞A549对CDDP耐受性增加8.9倍,与亲代敏感细胞A549相比,A549DDP胞浆内及核内CDDP积聚分别为亲代细胞的16.9%与24.3%,铂含量与CDDP浓度正相关;A549DDP外排CDDP的功能较A549明显增强,ICL形成量低84.1%,而修复功能增强2倍。结果提示:A549DDP细胞内CDDP积聚减少和修复功能增强是CDDP的主要耐药机理。

关 键 词:人肺腺癌  顺铂  耐药机理

Mechanison of Resistance of Human Cell Line A 549 DDP to Cisplatin
Zhan Maocheng Liu Xuyi Cai Peng et al Molecular Pharmacological Laboratory,School of Oncology,Beijing Medical University,Beijing. Mechanison of Resistance of Human Cell Line A 549 DDP to Cisplatin[J]. Chinese Journal of Clinical Oncology, 1998, 25(10): 726-728
Authors:Zhan Maocheng Liu Xuyi Cai Peng et al Molecular Pharmacological Laboratory  School of Oncology  Beijing Medical University  Beijing
Abstract:A resistant human lung adenocarcinoma cell line A 549 DDP was established by stepwise increasing content of cisplatin in the culture medium.The intracellular and intranuclear accumulation of cisplatin were measured by atomic absorption spectrometry. The interstrand cross linked DNA (ICL)was measured by ethidium bromide fluorescence assay. The removal of GS X was determined by FCM and fluorescence microscopy. The A 549 DDP cell line was 8.9 fold resistant to cisplatin than its parent cell line A 549 .The intracellular and intranuclear accumulation of cisplatin in the A 549 DDP cell line was 16.9 and 24.3 percent of A 549 cell line respectively. The repair rate in A 549 DDP cell line was 2 fold higher than that in A 549 . The resistant cell line A 549 DDP extruded CDDP more quickly than the sensitive cell line A 549 . The results mentioned above showed that decreased accumulation of CDDP may be a key mechanism in CDDP resistance,while the increased Pt DNA repair capacity may play a role in CDDP resistance.
Keywords:Human lung adenocarcinoma Cisplatin Resistance mechanism  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号